Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. As a Clinical Trial Manager, you will oversee the execution of Revolution Medicines clinical studies, including managing clinical CROs, reviewing monitoring reports, and ensuring compliance with FDA regulations and GCP guidelines.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines